US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,811.11

-13.8750-0.76%

Number of Gainers:8

Number of Losers:10

Number of Flat:1

PE:- -

High:1,831.56

Open:1,825.61

Low:1,802.81

Close:1,824.99

Volume:90.97M

Turnover:8.22B

Market Cap:1.47T

Float Cap:1.44T

Loading ...

AstraZeneca Gets US FDA Priority Review for Investigative Bladder Cancer Therapy

MT Newswires Live

INLIF Stock Is Trending: Here's Why it Skyrocketed Over 93% After Hours

Benzinga Earnings

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Moderately bullish activity in Pfizer with shares up 0.9%

BioNTech CEO Uğur Şahin Disposes of USD 6,850,514.3 in Common Shares

Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know

Pfizer’s Japanese RSV Vaccine Study Wraps Up, Expanding Adult Market Potential

AstraZeneca PLC Stock Falls Thursday, Outperforms Market

FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.

Pfizer call volume above normal and directionally bullish

Analysts Offer Insights on Healthcare Companies: NanoViricides (NNVC) and Ionis Pharmaceuticals (IONS)

EOG Resources Announces Ann Janssen's Retirement and Jeff Hibbard as Next CFO

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)

AstraZeneca (AZN) Receives a Buy from RBC Capital

RBC Capital Remains a Hold on Pfizer (PFE)

BridgeBio's Heart Drug Shows Superior Real-World Results Over Pfizer's Rival Treatment

NYSE Most Active Issues

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/BK4568/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1811.1105,"timestamp":1790971199999,"preClose":1824.9855,"halted":0,"volume":90970843,"delay":0,"changeRate":-0.007603,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-13.875,"latestTime":"10-02 16:00:00 EDT","open":1825.6097,"high":1831.557,"low":1802.8068,"amount":8217801901.581731,"amplitude":0.015754,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.847322,"peRate":47.020292,"turnoverRate":0.006557,"increases":8,"decrements":10,"flats":1,"marketCap":1472930542925.5,"floatMarketCap":1437881726786},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1831.557,"amplitude":0.015754,"preClose":1824.9855,"low":1802.8068,"pbRate":"4.847322","latestPrice":1811.1105,"volume":90970843,"delay":0,"open":1825.6097,"prevYearClose":1637.1339,"prevWeekClose":1903.4879,"prevMonthClose":1862.664,"prevQuarterClose":1862.664,"fiveDayClose":1903.4879,"twentyDayClose":1915.5433,"sixtyDayClose":1751.8207,"secType":"PLATE","market":"US","turnoverRate":0.006557,"peRate":47.020292,"marketCap":1472930542925.5,"floatMarketCap":1437881726786,"timestamp":1790971199999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":10,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670445225","title":"AstraZeneca Gets US FDA Priority Review for Investigative Bladder Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2670445225","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670445225?lang=en_us&edition=fundamental","pubTime":"2026-09-25 15:48","pubTimestamp":1790322524,"startTime":"0","endTime":"0","summary":"AstraZeneca  said Friday the US Food and Drug Administration granted priority review to its application for an Imfinzi combination therapy to treat muscle-invasive bladder cancer.The treatment is intended for patients who cannot or choose not to receive cisplatin-based chemotherapy.The submission is based on a phase 3 trial, which showed the perioperative therapy delivered event-free and overall survival improvements compared with bladder removal surgery with or without approved secondary treatments, the company said.AstraZeneca said the FDA is expected to make a regulatory decision in Q4.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","LU2237443895.HKD","LU2468319806.SGD","LU0310800379.SGD","LU2237443382.USD","AZNH","BK4585","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","LU2237443978.SGD","LU0889565916.HKD","LU0432979614.USD","LU2237443622.USD","LU2089984988.USD","LU2237443465.HKD","AZN","LABU","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU0128525929.USD","LU2417539215.USD","LU0058720904.USD","BK4588","LU0109394709.USD","BK4568","LU0289739699.SGD","BK4007","LU0029864427.USD","LU1267930573.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670417369","title":"INLIF Stock Is Trending: Here's Why it Skyrocketed Over 93% After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2670417369","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670417369?lang=en_us&edition=fundamental","pubTime":"2026-09-25 11:49","pubTimestamp":1790308178,"startTime":"0","endTime":"0","summary":"INLIF shares soared 93% after hours Thursday following strong first-half revenue growth and a return to profitability.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/09/61988300/inlif-stock-jumps-93-percent-after-hours-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","BK4150","IDNA","BK4551","LGHT","RSI","BK4534","BK4532","BK4588","MRNA","MRNY","BK4568","BK4501","BK4139","BETZ","BK4533","BK4548","ODDZ","BK4161","ODDS","INLF","WDNA","BK4585","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670137914","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670137914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670137914?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:25","pubTimestamp":1790285100,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slipped 3.20% to $1.21 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.01% to 26,939.37 and the Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Inovio Pharmaceuticals Inc. closed 55.51% below its 52-week high of $2.72, which the company reached on December 17th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  rose 0.82% to $28.41.Trading volume  remained 1.4 million below its 50-day average volume of 4.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INO","BK4583","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413895","title":"Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413895?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:50","pubTimestamp":1790283042,"startTime":"0","endTime":"0","summary":"Health Rounds: Genetic discovery yields clues toward reversal of Alzheimer's brain damageSept 24 -Hello Health Rounds readers!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL1N45G0ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","BK4585","LU2324357040.USD","LU0289739699.SGD","MEDI","LU2087621335.USD","LU0122379950.USD","LU1023059063.AUD","LU1934455194.USD","LU0823416689.USD","IE00B19Z3B42.SGD","BBH","GILD","BK4588","TMED","BK4583","LU0965509010.AUD","LU1037948541.HKD","IE00BSNM7G36.USD","LU0234570918.USD","LU1061106388.HKD","BK4532","IE0002270589.USD","LU1934455863.HKD","BIB","BMED","BK4550","TBXU","IBBQ","SG9999015952.SGD","LU1934455277.USD","LU0861579265.USD","LU2357627491.SGD","LU0058720904.USD","LU1037948897.HKD","LU1674673428.USD","BK4568","BK4139","SG9999015945.SGD","LU0882574055.USD","IE00BKVL7J92.USD","LU0965509101.SGD","IBB","LU2089984988.USD","SG9999015978.USD","BK4578","IE00B19Z3581.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670180864","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670180864","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670180864?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:35","pubTimestamp":1790282100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.11% to $149.69 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 4.83% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Pfizer Inc.  rose 0.82% to $28.41, and Abbott Laboratories  fell 2.34% to $101.07.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","BK4585","IE0002270589.USD","LU0122379950.USD","LU0965509101.SGD","BK4532","BK4566","GILD","LU1585245621.USD","IE00B19Z3581.USD","TMED","BK4139","TBXU","BMED","IE00B7SZLL34.SGD","LU0965509283.SGD","LU1037948897.HKD","LU2089984988.USD","LU0889565916.HKD","LU0965509010.AUD","LU0320765992.SGD","LU0861579265.USD","SG9999015986.USD","LU1674673428.USD","LU0965508806.USD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","LU0289739699.SGD","LU1061106388.HKD","BK4568","LU2087621335.USD","LU1037948541.HKD","MEDI","BIB","IE00B3T34201.USD","LU1571399168.USD","IE00B19Z3B42.SGD","LU2357627491.SGD","SG9999015952.SGD","SG9999015978.USD","IBB","LU1674673691.USD","BK4583","LU1778281490.HKD","LU1839511570.USD","LU1066051498.USD","LU0234570918.USD","BBH","LU0109394709.USD","LU2112291526.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU1057294990.SGD","BK4550","BK4588","LU1934455194.USD","LU1934455863.HKD","LU2468319806.SGD","LU1934455277.USD","LU0882574055.USD","LU1430594728.SGD","LU2324357040.USD","LU0058720904.USD","LU0859254822.USD","LU1023059063.AUD","LU0823416689.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670184794","title":"Moderna Inc. Stock Advances 7.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670184794","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670184794?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:33","pubTimestamp":1790281980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 7.0% to $194.82 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 26,939.37 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $192.31, which the company reached on September 23rd.The stock outperformed some of its peers, as Johnson & Johnson rose 0.6% to $270.68, Pfizer Inc. rose 0.8% to $28.41, and Gilead Sciences Inc. fell 1.11% to $149.69.Trading volume totaled 16.4 million, compared to the 50-day average of 18.6 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMED","LU0965509101.SGD","BIB","LU2468319806.SGD","BK4534","BK4550","MRNX","LU0861579265.USD","GNOM","TBXU","LU0234570918.USD","LU1430594728.SGD","LU1066051498.USD","LU2112291526.USD","BK4532","LU0965509283.SGD","LU1057294990.SGD","LU1066053197.SGD","BMED","BBH","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU2324357040.USD","IBBQ","LU0965508806.USD","LU1674673428.USD","LU0965509010.AUD","BK4568","WDNA","IE0002270589.USD","MEDI","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU2357627491.SGD","BK4533","IBB","IE00B3T34201.USD","LU0289739699.SGD","LU1778281490.HKD","IE00B19Z3B42.SGD","LGHT","LU0859254822.USD","GILD","MRNA","SG9999015952.SGD","LU1934455863.HKD","MRNY","LU1571399168.USD","BK4551","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670141875","title":"Moderately bullish activity in Pfizer with shares up 0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670141875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670141875?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:30","pubTimestamp":1790281833,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Pfizer (PFE), with shares up 26c, or 0.9%, near $28.43. Options volume running well above average with 131k contract...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-pfizer-with-shares-up-0-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-pfizer-with-shares-up-0-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","SG9999003800.SGD","SG9999002232.USD","LU0868494617.USD","LU0321505868.SGD","BK4599","IE00BLSP4452.SGD","SG9999011175.SGD","LU0225284248.USD","LU0985481810.HKD","BK4581","SG9999002224.SGD","LU0170899867.USD","BK4592","IE00BLSP4239.USD","BK4550","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0225771236.USD","LU0306806265.USD","LU1894683348.USD","BK4534","BK4007","LU1883839398.USD","IE0002270589.USD","PFE","BK4585","LU0234572021.USD","LU1894683264.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1066053197.SGD","LU2596442595.SGD","LU0306807586.USD","LU0321505439.SGD","LU0122379950.USD","LU1066051498.USD","SG9999001176.USD","IE00B3T34201.USD","SGXZ57979304.SGD","LU0058720904.USD","LU1023059063.AUD","BK4588","LU0456855351.SGD","LU0289739699.SGD","SG9999001176.SGD","OZEM","SG9999013999.USD","IE000M9KFDE8.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670741890","title":"BioNTech CEO Uğur Şahin Disposes of USD 6,850,514.3 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2670741890","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670741890?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:26","pubTimestamp":1790281605,"startTime":"0","endTime":"0","summary":"BioNTech CEO Uur ahin disposes of USD 6,850,514.3 in common sharesUur ahin, chief executive officer, sold 69,000 ordinary shares in BioNTech on Sept. 23-24.Sales priced at USD 99.4027 and USD 98.9913;","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDLb50cTy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioNTech CEO Uğur Şahin Disposes of USD 6,850,514.3 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","BK4585","BK4568","BK4548","BK4588","BNTX","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670909974","title":"Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2670909974","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670909974?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:15","pubTimestamp":1790277319,"startTime":"0","endTime":"0","summary":"• Moderna shares rose as investors welcomed its transformation into a diversified biotechnology platform.\n• Anticipation for Phase 3 oncology trial data and new respiratory approvals drove buying pressure.\n• The company reported $1.94 billion in annual revenue and a net loss.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262185597-market-movers-mrna-20260924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4548","GNOM","MRNY","BK4568","LGHT","BK4585","BK4533","BK4534","BK4551","BK4588","WDNA","MRNX","MRNA","BK4501","IDNA","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492996","title":"Pfizer’s Japanese RSV Vaccine Study Wraps Up, Expanding Adult Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492996?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:30","pubTimestamp":1790267441,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has completed a Phase 3 study in Japan testing its RSVpreF...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-japanese-rsv-vaccine-study-wraps-up-expanding-adult-market-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-japanese-rsv-vaccine-study-wraps-up-expanding-adult-market-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BBT3K403.USD","BK4550","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0306807586.USD","SG9999001176.SGD","LU2596442595.SGD","LU0985481810.HKD","SG9999002224.SGD","BK4534","BK4599","LU0321505439.SGD","LU1894683264.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","LU1066053197.SGD","LU0170899867.USD","LU1057294990.SGD","SG9999013999.USD","BK4581","LU0225284248.USD","LU1066051498.USD","LU0456855351.SGD","BK4007","SGXZ57979304.SGD","IE00BLSP4452.SGD","BK4568","LU0122379950.USD","LU0225771236.USD","BK4533","LU1883839398.USD","IE0002270589.USD","IE00BLSP4239.USD","SG9999011175.SGD","IE00B3T34201.USD","BK4588","BK4585","LU0234572021.USD","LU0868494617.USD","LU0289739699.SGD","PFE","SG9999001176.USD","SG9999002232.USD","OZEM","LU0321505868.SGD","BK4592","LU1023059063.AUD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670494719","title":"AstraZeneca PLC Stock Falls Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2670494719","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670494719?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:01","pubTimestamp":1790265660,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC shed 0.6% to SEK1,630.00 Thursday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 1.3% to 2,614.61.This was the stock's second consecutive day of losses.The company closed SEK295.50 short of its 52-week high of SEK1,925.50, which the company achieved on April 10, 2026.Trading volume was 353,792, compared to the 50-day average trading volume of 611,665.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU0432979614.USD","LU2237443895.HKD","LU0889565916.HKD","LU0320765992.SGD","LU2468319806.SGD","LU0708994859.HKD","LU0058720904.USD","AZN","LU2237443622.USD","LU0029864427.USD","LU0310800379.SGD","LU1267930573.SGD","LU2089984988.USD","BK4007","LU2237443978.SGD","BK4568","LU2237443465.HKD","LU2237443549.SGD","AZNH","IE00B3T34201.USD","BK4588","LU2456880835.USD","BK4585","LU2236285917.USD","LU0289739699.SGD","LU0109394709.USD","LU0128525929.USD","LU1829250122.USD","LU2417539215.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499070","title":"FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499070","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499070?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:52","pubTimestamp":1790261520,"startTime":"0","endTime":"0","summary":"Mizuho's Bradley Bowers thinks the boost will be substantial. He wrote Tuesday that sales doubled in the launch years of other cancer-screening products-like colon cancer stool test Cologuard from the Exact Sciences unit of Abbott, or the colon cancer blood test Shield from Guardant Health.Galleri screens a person's blood sample for bits of DNA showing features typical of cancer cells. It tells you if it has found a general signal of cancer somewhere in your body-\"Cancer Signal Detected\"-and makes its best guess at the kind of tissue where the cancer is hiding.Clinical trials showed Galleri can detect cancers for which there is no standard screen, such as cancer of the ovary or pancreas. Grail's two big clinical trials showed that it rarely tells you that you have cancer when you don't. When you do have cancer, the test finds it on average about 50% of the 60% of the time.That is good performance, compared with other widely used screens, like the mammogram. Grail plans to tell customer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4196","LFSC","BK4551","BK4082","ABT","LU0122379950.USD","TMED","LABU","LU1061106388.HKD","BK4585","LU2089984988.USD","FFOX","LU1721429402.USD","BK4588","LU1989763690.USD","SGXZ23171101.USD","LU0889565916.HKD","SG9999004303.SGD","LU2112291526.USD","BK4581","GNMX","LU1691799644.USD","SGXZ41872573.SGD","LU0868494617.USD","PJP","LU1670627923.USD","BK4568","LU0320765489.SGD","IE0002141913.USD","LU2468319806.SGD","GRAL","GH","SG9999002232.USD","EKG","HELX","LU1721429741.USD","BK4139","SG9999002224.SGD","LU2237957811.SGD","LU0289739699.SGD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0211331839.USD","PTH","GNOM","LU0882574055.USD","BK4535","IHI","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669492499","title":"Pfizer call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2669492499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669492499?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:25","pubTimestamp":1790259911,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Pfizer (PFE) with 38,277 calls trading, 3x expected, and implied vol increasing over 1 point to 22.81%. Nov-26 32 c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-call-volume-above-normal-and-directionally-bullish-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-call-volume-above-normal-and-directionally-bullish-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0456855351.SGD","IE00B19Z3581.USD","LU1894683264.USD","BK4568","IE0002270589.USD","LU0321505868.SGD","LU1066051498.USD","SG9999002224.SGD","LU0170899867.USD","PFE","BK4534","LU1883839398.USD","SG9999013999.USD","BK4581","LU1894683348.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","BK4599","SG9999003800.SGD","BK4592","SG9999001176.SGD","BK4588","IE00BLSP4452.SGD","LU0225284248.USD","BK4585","LU0234572021.USD","SG9999011175.SGD","LU0225771236.USD","LU0868494617.USD","SG9999001176.USD","LU0985481810.HKD","LU1023059063.AUD","LU0306806265.USD","LU1057294990.SGD","IE00BBT3K403.USD","BK4007","LU0058720904.USD","LU0122379950.USD","OZEM","LU2596442595.SGD","BK4533","LU0289739699.SGD","SG9999002232.USD","LU0306807586.USD","IE00B19Z3B42.SGD","BK4550","IE00B3T34201.USD","LU1066053197.SGD","IE000M9KFDE8.USD","LU0321505439.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669919495","title":"Analysts Offer Insights on Healthcare Companies: NanoViricides (NNVC) and Ionis Pharmaceuticals (IONS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669919495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669919495?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:30","pubTimestamp":1790256610,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on NanoViricides (NNVC) and Ionis Pharmaceuticals (IONS). NanoVirici...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nanoviricides-nnvc-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nanoviricides-nnvc-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","XBI","BK4585","BK4581","HCSG","BK4139","XLV","LU0128526141.USD","LU0029874061.USD","LABU","BK4588","BK4137","NNVC","IONS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669493147","title":"EOG Resources Announces Ann Janssen's Retirement and Jeff Hibbard as Next CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493147","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669493147?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:10","pubTimestamp":1790255400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUAS8RR8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","IE00B2Q91V27.USD","LU1057294990.SGD","PXE","LU0889566641.SGD","LU1291159041.SGD","LU1551013425.SGD","XLV","BMED","RXL","BK4568","JNJ","FTXN","MEDX","PJP","LU0882574055.USD","IE00BVYPNV92.GBP","GDOC","FCG","LU0640476718.USD","FTXH","IEO","EOG","LU0345770308.USD","LU1244550494.USD","LU2236285917.USD","FHLC","DRLL","LU0203347892.USD","LU0234570918.USD","BK4007","BK4533","LU1261432733.SGD","LU2896262040.SGD","LU0130517989.USD","LU1061106388.HKD","LU2750360997.AUD","JDOC","OILT","VHT","IE00BBT3K403.USD","IE00BLSP4452.SGD","IHE","LU0788109394.HKD","TRUH","IE0009355771.USD","IXJ","BK4585","IYH","LU0345769631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669049359","title":"Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669049359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669049359?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:50","pubTimestamp":1790254216,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aethlon Medical (AEMD) and Kyverna Therapeutics, I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aethlon-medical-aemd-and-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aethlon-medical-aemd-and-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0029874061.USD","XLV","BK4568","HCSG","BK4137","BK4585","BK4588","AEMD","XBI","BK4581","LABU","BK4082","BK4583","KYTX","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669458422","title":"AstraZeneca (AZN) Receives a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2669458422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669458422?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:46","pubTimestamp":1790214385,"startTime":"0","endTime":"0","summary":"In a report released on September 21, Trung Huynh from RBC Capital maintained a Buy rating on AstraZeneca, with a price target of p14,500.00. The c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443382.USD","LU0432979614.USD","LU2237443895.HKD","LU0889565916.HKD","LU0320765992.SGD","LU2468319806.SGD","LU0708994859.HKD","LU0058720904.USD","AZN","LU2237443622.USD","LU0029864427.USD","LU0310800379.SGD","LU1267930573.SGD","LU2089984988.USD","BK4007","LU2237443978.SGD","BK4568","LU2237443465.HKD","LU2237443549.SGD","AZNH","IE00B3T34201.USD","BK4588","LU2456880835.USD","BK4585","LU2236285917.USD","LU0289739699.SGD","LU0109394709.USD","LU0128525929.USD","LU1829250122.USD","LU2417539215.USD","GSIB","BK4207","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669255458","title":"RBC Capital Remains a Hold on Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669255458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669255458?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:46","pubTimestamp":1790214381,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Trung Huynh maintained a Hold rating on Pfizer on September 21 and set a price target of $25.00. The company’s shares closed ye...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-pfizer-pfe-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-pfizer-pfe-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OZEM","LU0234572021.USD","LU1883839398.USD","BK4592","IE0002270589.USD","BK4007","LU0058720904.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU1894683264.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU1066053197.SGD","BK4599","LU0225284248.USD","IE00B19Z3B42.SGD","PFE","SG9999002232.USD","BK4534","LU0225771236.USD","BK4581","IE00B19Z3581.USD","LU0868494617.USD","IE00B3T34201.USD","LU1057294990.SGD","LU0122379950.USD","LU0306807586.USD","LU0170899867.USD","LU1066051498.USD","SG9999011175.SGD","BK4550","LU0321505439.SGD","BK4533","SG9999001176.SGD","BK4585","IE00BBT3K403.USD","LU0289739699.SGD","LU2596442595.SGD","BK4588","SG9999001176.USD","LU0306806265.USD","SG9999003800.SGD","LU1894683348.USD","SGXZ57979304.SGD","LU0321505868.SGD","BK4568","LU1023059063.AUD","SG9999013999.USD","SG9999002224.SGD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123855393","title":"BridgeBio's Heart Drug Shows Superior Real-World Results Over Pfizer's Rival Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1123855393","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123855393?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:39","pubTimestamp":1790210367,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma announced on Wednesday that its heart disease therapy acoramidis, marketed as Attruby in the U.S., demonstrated superior performance compared to Pfizer's competing drug tafamidis,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","BK4534","LU0868494617.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4139","BK4585","LU1057294990.SGD","SG9999011175.SGD","SG9999001176.SGD","BK4599","BK4581","IE00B3T34201.USD","BK4568","SG9999002224.SGD","BK4588","IE00B19Z3B42.SGD","LU0306807586.USD","BK4533","LU1023059063.AUD","IE0002270589.USD","LU1066051498.USD","IE000M9KFDE8.USD","BK4505","LU0456855351.SGD","SGXZ57979304.SGD","LU0225771236.USD","SG9999003800.SGD","LU1894683348.USD","PFE","LU1883839398.USD","LU0170899867.USD","SG9999001176.USD","BBIO","LU0122379950.USD","SG9999013999.USD","BK4550","IE00BLSP4452.SGD","LU1894683264.USD","LU0289739699.SGD","LU0306806265.USD","LU0321505439.SGD","BK4007","LU0321505868.SGD","IE00BBT3K403.USD","LU0985481810.HKD","LU2596442595.SGD","OZEM","LU0234572021.USD","SG9999002232.USD","IE00B19Z3581.USD","LU0225284248.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431872","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431872?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:43","pubTimestamp":1790199780,"startTime":"0","endTime":"0","summary":"Nu Holdings Cl A              NU    62,809,850     13.62    -0.54     -3.81. Nike Cl B                    NKE    40,107,688     36.05    -0.05     -0.14. Bank of America              BAC    36,687,038     56.00    -0.20     -0.36. BitMine Immersion Techs     BMNR    35,969,374     27.46    -1.30     -4.52","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314106906.USD","LU1066053197.SGD","BAC","LU0477156797.USD","FTXO","LU0234570918.USD","LU0058720904.USD","LU0130518102.USD","SG9999001176.SGD","LU0477156953.USD","LU0225771236.USD","IE0001KFT4U8.USD","PATH","LU0310800965.SGD","KBWB","LU1668664300.SGD","LU1804176565.USD","BK4543","LU0256863811.USD","BK4568","IE00B7SZLL34.SGD","LU1280957306.USD","LU1057294990.SGD","LU0320765489.SGD","PATX","LU1035773651.USD","TFNS","LU1989771016.USD","UYG","LU0683600562.USD","SG9999002224.SGD","LU0648001328.SGD","LU1883839398.USD","OZEM","FNCL","XLF","PFE","BK4588","IE000M9KFDE8.USD","LU1894683348.USD","LU2129689431.USD","LU0070302665.USD","VFH","IYF","LU0052756011.USD","IYG","SG9999003800.SGD","LU0122379950.USD","LU1363072403.SGD","LU1201861249.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":9,"totalSize":235,"code":"91000000","status":"200"}]}}